Tolfenamic Acid

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
5	進行性核上性麻痺	1

5. 進行性核上性麻痺

臨床試験数 : 89 / 薬物数 : 107 - (DrugBank : 40) / 標的遺伝子数 : 65 - 標的パスウェイ数 : 108

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04253132 (ClinicalTrials.gov)	January 1, 2021	17/12/2019	Evaluation of Tolfenamic Acid in Individuals With PSP at 12-Weeks	A Phase 2a Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of ...	Progressive Supranuclear Palsy	Drug: Tolfenamic Acid;Drug: Placebos	NeuroTau, Inc.	The Cleveland Clinic	Not yet recruiting	40 Years	85 Years	All	24	Phase 1/Phase 2	United States

First Previous1Next Last